Published in AIDS Weekly, April 9th, 2001
"HIV 1 utilizes CD4 and the chemokine coreceptor for viral entry," I. Chaiken and colleagues explained in the journal Biochemistry. "The coreceptor CCR5 binding site on gp120 partially overlaps with the binding epitope of 17b, a neutralizing antibody of HIV 1."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.